DolCas Biotech develops collagen-infused chocolates to bridge beauty, indulgence

U.S.A. – DolCas Biotech, a nutraceutical ingredients company, has unveiled uniquely formulated collagen-infused chocolates, MoriKol® Chocolates, designed to support beauty from within.

MoriKol is a highly concentrated type I and III fish collagen tripeptide formula clinically validated to deliver effective results at minimal doses. Each 8-gram chocolate square contains 1 gram of MoriKol®.

At dosages as low as 1g/day, MoriKol’s very low molecular weight, tripeptide formulation easily adapts to capsules, tablets, gummies and other novel formulations that are hard to achieve with bulkier collagen powders. This advanced formulation ensures high bioavailability and rapid absorption. 

DolCas Biotech’s innovation enables the seamless incorporation of collagen into milk, dark, and white chocolates, while preserving the classic taste and texture that consumers expect.

Highlighting MoriKol’s low dosage advantage, KG Rao, founder and CEO of DolCas Biotech, stated, “Most collagen ingredients come in 5g-10g doses. Morikol’s low concentration makes it ideal for innovative delivery formats.”

Clinical research has confirmed MoriKol’s efficacy. 

In a trial involving 53 women, participants consuming 1g of MoriKol daily for 12 weeks reported significant improvements in skin elasticity and hydration, as well as a notable reduction in the appearance of wrinkles. 

Another study involving 64 participants with mild knee pain found that a 2g daily dose of MoriKol helped alleviate joint discomfort and reduce fluid accumulation.

The ingredient’s formulation is designed to facilitate the direct uptake of its tripeptides through the intestinal barrier, enhancing its efficacy. 

Previous research has shown that these tripeptides can stimulate collagen production, thereby benefiting the integrity of skin, bone, and connective tissue.

MoriKol is a versatile ingredient with wide functional food potential. Its neutral flavor and odor-free properties allow it to blend effortlessly into chocolate, making it an appealing choice for manufacturers aiming to deliver indulgence with added health benefits.

It is also non-GMO, allergen-friendly, and certified kosher and halal, accommodating diverse dietary preferences.

By merging clinically backed nutrition with everyday indulgence, MoriKol® Chocolates presents a new opportunity for chocolate manufacturers to innovate in the functional food space.

This crossover between confections and wellness positions DolCas Biotech at the forefront of a growing market trend, where indulgence and efficacy no longer need to be mutually exclusive.

About DolCas Biotech

Headquartered in New Jersey, DolCas Biotech, founded in 2007 as an extension of Orcas Naturals, is a vertically integrated developer and marketer of clinically supported nutraceutical ingredients. 

In 2017, Dolcas Biotech established its own manufacturing arm, DolCas Botanosys in Bikaner, India helping to vertically integrate the company and its sister corporations in the procurement of high quality ingredients. 

With a strong foundation in science and innovation, DolCas focuses on natural, functional solutions that align with modern consumer demands. 

The launch of MoriKol Chocolates reflects the company’s commitment to clean-label wellness and its ability to bring science-backed efficacy into indulgent, everyday formats, bridging the gap between clinical nutrition and functional confections.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.